“…Three patients with FHL3 in our series (38%) had CNS involvement at initial diagnosis, which is lower than previously reported rates (range, 60% -90%). 16,27,30 CNS involvement is the most discouraging clinical manifestation in FHL, and the association of CNS involvement with FHL3 might be related to the role of UNC13D in CNS function. 34 Two of these three patients succumbed to the disease, and also the single patient with FHL2 developed CNS involvement and died during the course of HLH-2004 treatment.…”